Inflection Points26 Oct 2023 14:28
We are due 2 prior to year end.
1. FDA confirmation of protocol change, this in itself will validate AVA6K.
2. Publishing of P1a data.
For me 1 will come mid- nov and should send the SP a lot higher than where it is languishing presently as I have already said it will validate AVA6K and the PreCision platform as a whole. Yes there are still many hurdles to clear but they have been somewhat lowered.
Then for me the icing on the cake is the P1 data just before Xmas including cohort 7. If it is as good as being purported the SP will then jump to another level altogether.
Only 8 weeks peeps GLA